Well Marc needs to spend some of our cash on paying for coverage. Nobody covers companies at this scale unless they are paid or to set up a CR. I personally don’t mind paid coverage provided it is high quality.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025